Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 7
Results: 14
Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)<sub>2</sub> fragment of anti-CD16 antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1053, doi. 10.1007/s00262-007-0437-6
- By:
- Publication type:
- Article
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 977, doi. 10.1007/s00262-007-0428-7
- By:
- Publication type:
- Article
Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 951, doi. 10.1007/s00262-007-0425-x
- By:
- Publication type:
- Article
In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1067, doi. 10.1007/s00262-007-0438-5
- By:
- Publication type:
- Article
CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 963, doi. 10.1007/s00262-007-0427-8
- By:
- Publication type:
- Article
Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1029, doi. 10.1007/s00262-007-0434-9
- By:
- Publication type:
- Article
Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 987, doi. 10.1007/s00262-007-0429-6
- By:
- Publication type:
- Article
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1079, doi. 10.1007/s00262-007-0439-4
- By:
- Publication type:
- Article
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1039, doi. 10.1007/s00262-007-0435-8
- By:
- Publication type:
- Article
Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 997, doi. 10.1007/s00262-007-0430-0
- By:
- Publication type:
- Article
Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1007, doi. 10.1007/s00262-007-0431-z
- By:
- Publication type:
- Article
A33 antigen displays persistent surface expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1017, doi. 10.1007/s00262-007-0433-x
- By:
- Publication type:
- Article
Local therapy of cancer with free IL-2.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 931, doi. 10.1007/s00262-008-0455-z
- By:
- Publication type:
- Article
Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1091, doi. 10.1007/s00262-007-0446-5
- By:
- Publication type:
- Article